Daniel J. Diekema, MD, MS

Portrait
Director, Division of Infectious Diseases
Clinical Professor of Internal Medicine - Infectious Diseases
Clinical Professor of Pathology

Contact Information

Primary Office: SW54-15 GH
Iowa City, IA 52242
319-384-5626

Education

MD, Vanderbilt University School of Medicine
MS, Preventive Medicine, University of Iowa College of Medicine

Resident, Internal Medicine, University of Virginia
Fellow, Infectious Diseases, The University of Iowa Hospitals and Clinics
Fellow, Clinical Microbiology, The University of Iowa Hospitals and Clinics

Licensure and Certifications

Medical Microbiology - American Board of Medical Microbiology
Infectious Diseases - American Board of Internal Medicine
Internal Medicine - American Board of Internal Medicine
State of Medical License - Iowa Board of Medicine

Research Summary

Interests: Several aspects of hospital epidemiology and clinical mycology, including the epidemiology of invasive fungal infections in hospitalized patients and the use of molecular typing in infection control and antimicrobial resistance control.

Publications

Vu, B. G., Stach, C. S., Salgado-Pabon, W., Diekema, D. J., Gardner, S. E. & Schlievert, P. M. (2014). Superantigens of Staphylococcus aureus from Patients with Diabetic Foot Ulcers. J Infect Dis, 210(12), 1920-1927. PMID: 24951827.

Pfaller, M. A., Diekema, D. J., Procop, G. W. & Wiederhold, N. P. (2014). Multicenter evaluation of the new Vitek 2 yeast susceptibility test using new CLSI clinical breakpoints for fluconazole. Journal of clinical microbiology, 52(6), 2126-30. PMID: 24719450.

Matsumoto, E., Boyken, L., Tendolkar, S., McDanel, J., Castanheira, M., Pfaller, M. & Diekema, D. (2014). Candidemia surveillance in Iowa: emergence of echinocandin resistance. Diagnostic microbiology and infectious disease, 79(2), 205-8. PMID: 24666704.

Diekema, D. J., Richter, S. S., Hellmann, K. P., Dohrn, C. L., Riahi, F., Tendolkar, S., McDanel, J. S. & Doern, G. V. (2014). Continued Emergence of USA300 Methicillin-Resistant Staphylococcus aureus in the United States: Results from a Nationwide Surveillance Study. Infection Control and Hospital Epidemiology, 35(3), 285-92. PMID: 24521595 - in process.

Pfaller, M. A., Espinel-Ingroff, A., Bustamente, B., Canton, E., Diekema, D. J., Fothergill, A., Fuller, J., Gonzalez, G. M., Guarro, J. & Las-Floerl, C. (2014). Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. Antimicrob Agents Chemother, 58(2), 916-22. DOI: doi: 10.1128/AAC.02020-13.

El-Herte, R. I., Schouweiler, K. E., Farah, R. S., Arbulu, R., Diekema, D. J., Wanat, K. A. & Ford, B. A. (2014). Phaeoacremonium Parasiticum Phaeohyphomycosis in a Patient with Systemic Lupus Erythematosus Treated Successfully with Surgical Debridement and Voriconazole: A Case Report and Review of the Literature. IDCases, 1(4), 84-88. DOI: 10.1016/j.idcr.2014.10.004.

Diekema, D. J., Richter, S. S., Heilmann, K. P., Dohrn, C. L., Crispell, E. K., Riahi, F., McDanel, J. S., Satola, S. W. & Doern, G. V. (2014). Activity of Vancomycin, Ceftaroline, and Mupirocin Against Staphylococcus aureus from a 2011 National Surveillance Study in the United States. Antimicrob Agents Chemotherapy,(58), 740-45.

Pfaller, M. A., Messer, S. A., Diekema, D. J., Jones, R. N. & Castanheira, M. (2014). Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria. Journal of clinical microbiology, 52(1), 108-14. PMID: 24153129.

Haleem, A., Schultz, J. S., Heilmann, K. P., Dohrn, C. L., Diekema, D. J. & Gardner, S. E. (2014). Concordance of nasal and diabetic foot ulcer staphylococcal colonization. Diagnostic Microbiology and Infectious Disease, 79(1), 85–89. DOI: 10.1016/j.diagmicrobio.2014.01.014.

Pfaller, M. A., Diekema, D. J., Jones, R. N. & Castanheira, M. (2014). Use of Anidulafungin as a Surrogate Marker to Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida using CLSI Methods and Interpretive Criteria. J Clin Microbiol, 52(9), 3223-3229. PMID: 24951808.

Morgan, D. J., Kaye, K. S. & Diekema, D. J. (2014). Reconsidering isolation precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. JAMA, 312(14), 1395-6. PMID: 25291571.

Richter, S. S., Diekema, D. J., Heilmann, K. P., Dohrn, C. L., Riahi, F. & Doern, G. V. (2014). Changes in Pneumococcal Serotypes and Antimicrobial Resistance After Introduction of the 13-Valent Conjugate Vaccine in the United States. Antimicrob Agents Chemother, 58(11), 6484-9. PMID: 25136018.

Feazel, L. M., Malhotra, A., Perencevich, E. N., Kaboli, P., Diekema, D. J. & Schweizer, M. L. (2014). Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy, 69(7), 1748-54. PMID: 24633207.

Ren, P., Luo, M., Ghannoum, M. A., Isham, N., Diekema, D. J., Pfaller, M. A., Messer, S., Lockhart, S. R., Iqbal, N. & Chaturvedi, V. (2014). Multilaboratory Testing of Antifungal Drug Combinations against Candida Species and Aspergillus Fumigatus: Utility of One-Hundred Percent Inhibition as the End-point. Antimicrob Agents Chemother. PMID: 25512402.

Reznikov, L. R., Abou Alaiwa, M. H., Dohrn, C. L., Gansemer, N. D., Diekema, D. J., Stoltz, D. A. & Welsh, M. J. (2014). Antibacterial properties of the CFTR potentiator ivacaftor. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 13(5), 515-9. PMID: 24618508.

Pfaller, M. A., Neofytos, D., Diekema, D., Azie, N., Meier-Kriesche, H. U., Quan, S. P. & Horn, D. (2014). Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004-2008. (Vols. 9). (7), pp. e101510. PLoS One. DOI: doi: 10.1371/journal.pone.0101510.

McDanel, J. S., Ward, M. A., Leder, L., Schweizer, M. L., Dawson, J. D., Diekema, D. J., Smith, T. C., Chrischilles, E. A., Perencevich, E. N. & Herwaldt, L. A. (2014). Methicillin-resistant Staphylococcus aureus prevention practices in hospitals throughout a rural state. Am J Infect Control, 42(8), 868-73. PMID: 25087139.

Diekema, D. J., Pfaller, M. A. (2013). Rapid detection of antibiotic-resistant organism carriage for infection prevention. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56(11), 1614-20. PMID: 23362298.

Richter, S. S., Heilmann, K. P., Dohrn, C. L., Riahi, F., Diekema, D. J. & Doern, G. V. (2013). Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.). Emerging infectious diseases, 19(7), 1074-83. PMID: 23763847.

Castanheira, M., Woosley, L. N., Diekema, D. J., Jones, R. N. & Pfaller, M. A. (2013). Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs. Journal of clinical microbiology, 51(1), 117-24. PMID: 23100350.

Quezada Joaquin, N. M., Diekema, D. J., Perencevich, E. N., Bailey, G., Winokur, P. L. & Schweizer, M. L. (2013). Long-term risk for readmission, methicillin-resistant Staphylococcus aureus (MRSA) infection, and death among MRSA-colonized veterans. Antimicrobial agents and chemotherapy, 57(3), 1169-72. PMID: 23254427.

Pfaller, M. A., Diekema, D. J., Procop, G. W. & Rinaldi, M. G. (2013). Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values. Diagnostic microbiology and infectious disease, 77(1), 37-40. PMID: 23870164.

Pedersen, M., Doyle, M. R., Beste, A., Diekema, D. J., Zimmerman, M. B. & Herwaldt, L. A. (2013). Survey of high school athletic programs in Iowa regarding infections and infection prevention policies and practices. The Iowa orthopaedic journal, 33, 107-13. PMID: 24027469.

McDanel, J. S., Murphy, C. R., Diekema, D. J., Quan, V., Kim, D. S., Peterson, E. M., Evans, K. D., Tan, G. L., Hayden, M. K. & Huang, S. S. (2013). Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents. Antimicrobial agents and chemotherapy, 57(1), 552-8. PMID: 23147721.

Richter, S. S., Heilmann, K. P., Dohrn, C. L., Riahi, F., Diekema, D. J. & Doern, G. V. (2013). Evaluation of pneumococcal serotyping by multiplex PCR and quellung reactions. Journal of clinical microbiology, 51(12), 4193-5. PMID: 24025905.

Castanheira, M., Woosley, L. N., Messer, S. A., Diekema, D. J., Jones, R. N. & Pfaller, M. A. (2013). Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates. Antimicrobial Agents and Chemotherapy, AAC.01674–13. PMID: 24126582.

Paul, S., Diekema, D. & Moye-Rowley, W. S. (2013). Contributions of Aspergillus fumigatus ATP-binding cassette transporter proteins to drug resistance and virulence. Eukaryotic cell, 12(12), 1619-28. PMID: 24123268.

Magill, S. S., Klompas, M., Balk, R., Burns, S. M., Deutschman, C. S., Diekema, D., Fridkin, S., Greene, L., Guh, A., Gutterman, D., Hammer, B., Henderson, D., Hess, D., Hill, N. S., Horan, T., Kollef, M., Levy, M., Septimus, E., Vanantwerpen, C., Wright, D. & Lipsett, P. (2013). Developing a new, national approach to surveillance for ventilator-associated events: executive summary. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 57(12), 1742-6. PMID: 24280662.

Talbot, T. R., Bratzler, D. W., Carrico, R. M., Diekema, D. J., Hayden, M. K., Huang, S. S., Yokoe, D. S. & Fishman, N. O. (2013). Public reporting of health care-associated surveillance data: recommendations from the healthcare infection control practices advisory committee. Annals of internal medicine, 159(9), 631-5. PMID: 24189597.

Richter, S. S., Diekema, D. J., Heilmann, K. P., Dohrn, C. L., Crispell, E. K., Riahi, F., McDanel, J. S., Satola, S. W. & Doern, G. V. (2013). Activity of Vancomycin, Ceftaroline, and Mupirocin Against Staphylococcus aureus from a 2011 National Surveillance Study in the United States. Antimicrobial Agents and Chemotherapy, AAC.01915–13. PMID: 24247138.

Lepak, A. J., Marchillo, K., VanHecker, J., Diekema, D. & Andes, D. R. (2013). Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model. Antimicrobial agents and chemotherapy, 57(11), 5642-8. PMID: 24002092.

Storm, J. C., Diekema, D. J., Kroeger, J. S., Johnson, S. J. & Johannsson, B. (2012). Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus. Antimicrobial resistance and infection control, 1(1), 19. PMID: 22958379.

Doern, G. V., Diekema, D. J., Heilmann, K. P., Dohrn, C. L., Riahi, F. & Richter, S. S. (2012). In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011. Antimicrobial agents and chemotherapy, 56(6), 3406-8. PMID: 22491687.

Cluck, D., Williamson, J. C., Glasgo, M., Diekema, D. & Sherertz, R. (2012). Bacterial contamination of an automated pharmacy robot used for intravenous medication preparation. Infection control and hospital epidemiology, 33(5), 517-20. PMID: 22476280.

Cosgrove, S. E., Seo, S. K., Bolon, M. K., Sepkowitz, K. A., Climo, M. W., Diekema, D. J., Speck, K., Gunaseelan, V., Noskin, G. A., Herwaldt, L. A., Wong, E. & Perl, T. M. (2012). Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention. Infection control and hospital epidemiology, 33(4), 374-80. PMID: 22418633.

Diekema, D., Arbefeville, S., Boyken, L., Kroeger, J. & Pfaller, M. (2012). The changing epidemiology of healthcare-associated candidemia over three decades. Diagnostic microbiology and infectious disease, 73(1), 45-8. PMID: 22578938.

Castanheira, M., Duncanson, F. P., Diekema, D. J., Guarro, J., Jones, R. N. & Pfaller, M. A. (2012). Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods. Antimicrobial agents and chemotherapy, 56(1), 352-7. PMID: 22083469.

Johannsson, B., Johnson, S. J., Ernst, E. J., Beekmann, S. E., Herwaldt, L., Diekema, D. J. & Polgreen, P. M. (2012). Antimicrobial therapy for bloodstream infection due to methicillin-susceptible Staphylococcus aureus in an era of increasing methicillin resistance: opportunities for antimicrobial stewardship. (Vols. 46). (6), pp. 904-5. The Annals of pharmacotherapy. PMID: 22669794.

Dressler, A. E., Scheibel, R. P., Wardyn, S., Harper, A. L., Hanson, B. M., Kroeger, J. S., Diekema, D. J., Bender, J. B., Gray, G. C. & Smith, T. C. (2012). Prevalence, antibiotic resistance and molecular characterisation of Staphylococcus aureus in pigs at agricultural fairs in the USA. The Veterinary Record, 170(19), 495. PMID: 22505242.

Pfaller, M. A., Espinel-Ingroff, A., Canton, E., Castanheira, M., Cuenca-Estrella, M., Diekema, D. J., Fothergill, A., Fuller, J., Ghannoum, M., Jones, R. N., Lockhart, S. R., Martin-Mazuelos, E., Melhem, M. S., Ostrosky-Zeichner, L., Pappas, P., Pelaez, T., Peman, J., Rex, J. & Szeszs, M. W. (2012). Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. Journal of clinical microbiology, 50(6), 2040-6. PMID: 22461672.

Schweizer, M., Graham, M., Ohl, M., Heilmann, K., Boyken, L. & Diekema, D. (2012). Novel hospital curtains with antimicrobial properties: a randomized, controlled trial. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 33(11), 1081-5. PMID: 23041804.

Ohl, M., Schweizer, M., Graham, M., Heilmann, K., Boyken, L. & Diekema, D. (2012). Hospital privacy curtains are frequently and rapidly contaminated with potentially pathogenic bacteria. American journal of infection control, 40(10), 904-6. PMID: 22464039.

Pfaller, M. A., Diekema, D. J. (2012). Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. Journal of clinical microbiology, 50(9), 2846-56. PMID: 22740712.

Pfaller, M., Neofytos, D., Diekema, D., Azie, N., Meier-Kriesche, H. U., Quan, S. P. & Horn, D. (2012). Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008. Diagnostic microbiology and infectious disease, 74(4), 323-31. PMID: 23102556.

Beekmann, S. E., Diekema, D. J., Huskins, W. C., Herwaldt, L., Boyce, J. M., Sherertz, R. J. & Polgreen, P. M. (2012). Diagnosing and reporting of central line-associated bloodstream infections. Infection control and hospital epidemiology, 33(9), 875-82. PMID: 22869260.

Schweizer, M., Ward, M., Cobb, S., McDanel, J., Leder, L., Wibbenmeyer, L., Latenser, B., Diekema, D. & Herwaldt, L. (2012). The epidemiology of methicillin-resistant Staphylococcus aureus on a burn trauma unit. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 33(11), 1118-25. PMID: 23041810.

Leekha, S., Diekema, D. J. & Perencevich, E. N. (2012). Seasonality of staphylococcal infections. Clinical Microbiology and Infection, 18(10), 927–933. DOI: 10.1111/j.1469-0691.2012.03955.x.

Lepak, A., Castanheira, M., Diekema, D., Pfaller, M. & Andes, D. (2012). Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations. Antimicrobial agents and chemotherapy, 56(11), 5875-82. PMID: 22948870.

Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2011). Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program. Journal of clinical microbiology, 49(4), 1274-9. PMID: 21289155.

Chaturvedi, V., Ramani, R., Andes, D., Diekema, D. J., Pfaller, M. A., Ghannoum, M. A., Knapp, C., Lockhart, S. R., Ostrosky-Zeichner, L., Walsh, T. J., Marchillo, K., Messer, S., Welshenbaugh, A. R., Bastulli, C., Iqbal, N., Paetznick, V. L., Rodriguez, J. & Sein, T. (2011). Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial agents and chemotherapy, 55(4), 1543-8. PMID: 21282457.

Peterson, J. F., Pfaller, M. A., Diekema, D. J., Rinaldi, M. G., Riebe, K. M. & Ledeboer, N. A. (2011). Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp. Journal of clinical microbiology, 49(5), 1765-71. PMID: 21430096.

Pfaller, M. A., Espinel-Ingroff, A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2011). Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values. Journal of clinical microbiology, 49(3), 845-50. PMID: 21227994.

Kroeger, J., Diekema, D. J., Quan, V., Kim, D., Peterson, E., Evans, K., Tan, G., Hayden, M. K. & Huang, S. S. (2011). Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus from Long-Term Care Facility Patients.

Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2011). Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution. Journal of clinical microbiology, 49(2), 630-7. PMID: 21159940.

Chiang, H. Y., Steelman, V. M., Pottinger, J. M., Schlueter, A. J., Diekema, D. J., Greenlee, J. D., Howard, M. A. & Herwaldt, L. A. (2011). Clinical significance of positive cranial bone flap cultures and associated risk of surgical site infection after craniotomies or craniectomies. Journal of neurosurgery, 114(6), 1746-54. PMID: 21375380.

Herwaldt, L. A., Ward, M., Cobb, S., Leder, L., Kroeger, J. & Diekema, D. J. (2011). The Epidemiology of Methicillin-Resistant S. aureus on a Burn-Trauma Unit.

Leedom Larson, K. R., Harper, A. L., Hanson, B. M., Male, M. J., Wardyn, S. E., Dressler, A. E., Wagstrom, E. A., Tendolkar, S., Diekema, D. J., Donham, K. J. & Smith, T. C. (2011). Methicillin-resistant Staphylococcus aureus in pork production shower facilities. Applied and environmental microbiology, 77(2), 696-8. PMID: 21097587.

Pfaller, M., Boyken, L., Hollis, R., Kroeger, J., Messer, S., Tendolkar, S. & Diekema, D. (2011). Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles. Journal of clinical microbiology, 49(2), 586-90. PMID: 21123534.

Pfaller, M. A., Castanheira, M., Diekema, D. J., Messer, S. A. & Jones, R. N. (2011). Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method. Diagnostic microbiology and infectious disease, 71(3), 252-9. PMID: 21917395.

Diekema, D., Johannsson, B., Herwaldt, L., Beekmann, S., Jernigan, J., Kallen, A., Berrios-Torres, S. & Polgreen, P. (2011). Current practice in Staphylococcus aureus screening and decolonization. Infection control and hospital epidemiology, 32(10), 1042-4. PMID: 21931258.

Pfaller, M. A., Diekema, D. J., Andes, D., Arendrup, M. C., Brown, S. D., Lockhart, S. R., Motyl, M. & Perlin, D. S. (2011). Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 14(3), 164-76. PMID: 21353623.

Pfaller, M. A., Castanheira, M., Diekema, D. J., Messer, S. A. & Jones, R. N. (2011). Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida. Journal of clinical microbiology, 49(11), 3800-4. PMID: 21900519.

Richter, S. S., Satola, S. W., Crispell, E. K., Heilmann, K. P., Dohrn, C. L., Riahi, F., Costello, A. J., Diekema, D. J. & Doern, G. V. (2011). Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate-Level Resistance to Vancomycin in the United States. Journal of Clinical Microbiology, 49(12), 4203–4207. PMID: 21976769.

Mendes, R. E., Smith, T. C., Deshpande, L., Diekema, D. J., Sader, H. S. & Jones, R. N. (2011). Plasmid-borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United States. Diagnostic Microbiology and Infectious Disease, 71(2), 177-180. DOI: 10.1016/j.diagmicrobio.2011.06.009.

Richter, S. S., Heilmann, K. P., Dohrn, C. L., Riahi, F., Costello, A. J., Kroeger, J. S., Biek, D., Critchley, I. A., Diekema, D. J. & Doern, G. V. (2011). Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. Antimicrobial agents and chemotherapy, 55(9), 4154-60. PMID: 21709080.

Pfaller, M. A., Andes, D., Arendrup, M. C., Diekema, D. J., Espinel-Ingroff, A., Alexander, B. D., Brown, S. D., Chaturvedi, V., Fowler, C. L., Ghannoum, M. A., Johnson, E. M., Knapp, C. C., Motyl, M. R., Ostrosky-Zeichner, L. & Walsh, T. J. (2011). Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagnostic microbiology and infectious disease, 70(3), 330-43. PMID: 21546199.

Arbefeville, S. S., Zhang, K., Kroeger, J. S., Howard, W. J., Diekema, D. J. & Richter, S. S. (2011). Prevalence and genetic relatedness of methicillin-susceptible Staphylococcus aureus isolates detected by the Xpert MRSA nasal assay. Journal of clinical microbiology, 49(8), 2996-9. PMID: 21677066.

Lockhart, S. R., Frade, J. P., Etienne, K. A., Pfaller, M. A., Diekema, D. J. & Balajee, S. A. (2011). Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrobial agents and chemotherapy, 55(9), 4465-8. PMID: 21690285.

Pfaller, M. A., Diekema, D. J., Andes, D., Arendrup, M., Brown, S., Motyl, M. & Perlin, D. (2010). Clinical breakpoints for the echinocandins and Candida, revisited.

Richter, S. S., Heilmann, K., Dohrn, C., Riahi, F., Costello, A., Kroeger, J., Diekema, D. J. & Doern, G. V. (2010). Activity of ceftaroline against 4210 Staphylococcus aureus isolates from 43 United States centers, 2009.

Andrews, J. I., Coffin, J. E., Fleener, D. K. & Diekema, D. J. (2010). Association of Toll Like receptor 2 (TLR2) genetic polymorphisms with Staphylococcus aureus colonization during pregnancy.

Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S., Tendolkar, S. & Diekema, D. J. (2010). Comparison of broth microdilution methods of EUCAST and CLSI for testing fluconazole, posaconazole and voriconazole against Candida spp.

Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2010). Use of epidemiologic cutoff values (ECVs) to examine 9-year trends in susceptibility of Aspergillus species to the triazoles.

Diekema, D. J., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Pfaller, M. A. (2010). Comparison of the broth microdilution methods of EUCAST and the CLSI for testing itraconazole, posaconazole and voriconazole against Aspergillus species.

Diekema, D. J., Pfaller, M. A. (2010). Utility of Antifungal Susceptibility Testing and Clinical Correlations.

Mendes, R., Smith, T., Deshpande, L. M., Diekema, D. J., Sader, H. S. & Jones, R. N. (2010). Plasmid borne vga(A)-encoding gene in methicillin-resistant Staphylococcus aureus (MRSA) ST-398 from swine and swine farmers in the United States.

Richter, S. S., Heilmann, K., Dohrn, C., Kroeger, J., Diekema, D. J. & Doern, G. V. (2010). Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the United States, 2009.

Pfaller, M. A., Diekema, D. J. (2010). Epidemiology of invasive mycoses in North America. Critical reviews in microbiology, 36(1), 1-53. PMID: 20088682.

Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., Jones, R. N., Turnidge, J. & Diekema, D. J. (2010). Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. Journal of clinical microbiology, 48(1), 52-6. PMID: 19923478.

Andes, D., Diekema, D. J., Pfaller, M. A., Bohrmuller, J., Marchillo, K. & Lepak, A. (2010). In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species. Antimicrobial agents and chemotherapy, 54(6), 2497-506. PMID: 20385855.

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Barton, R., Bijie, H., Bille, J., Chang, S. C., da Luz Martins, M., Duse, A., Dzierzanowska, D., Ellis, D., Finquelievich, J., Gould, I., Gur, D., Hoosen, A., Lee, K., Mallatova, N., Mallie, M., Peng, N. G., Petrikos, G., Santiago, A., Trupl, J., VanDen Abeele, A. M., Wadula, J. & Zaidi, M. (2010). Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. Diagnostic microbiology and infectious disease, 67(2), 162-71. PMID: 20338711.

Espinel-Ingroff, A., Diekema, D. J., Fothergill, A., Johnson, E., Pelaez, T., Pfaller, M. A., Rinaldi, M. G., Canton, E. & Turnidge, J. (2010). Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Journal of clinical microbiology, 48(9), 3251-7. PMID: 20592159.

Pfaller, M. A., Andes, D., Diekema, D. J., Espinel-Ingroff, A. & Sheehan, D. (2010). Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 13(6), 180-95. PMID: 21050800.

Peterson, L. R., Diekema, D. J. (2010). To screen or not to screen for methicillin-resistant Staphylococcus aureus. Journal of clinical microbiology, 48(3), 683-9. PMID: 20071548.

Perencevich, E. N., Diekema, D. J. (2010). Decline in invasive MRSA infection: where to go from here?. JAMA : the journal of the American Medical Association, 304(6), 687-9. PMID: 20699464.

Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2010). Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods. Diagnostic microbiology and infectious disease, 67(1), 56-60. PMID: 20207095.

Castanheira, M., Woosley, L. N., Diekema, D. J., Messer, S. A., Jones, R. N. & Pfaller, M. A. (2010). Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains. Antimicrobial agents and chemotherapy, 54(6), 2655-9. PMID: 20368396.

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W. & Ling, T. A. (2010). Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. Journal of clinical microbiology, 48(4), 1366-77. PMID: 20164282.

Polgreen, P. M., Beekmann, S. E., Diekema, D. J. & Sherertz, R. J. (2010). Wide variability in the use of antimicrobial lock therapy and prophylaxis among infectious diseases consultants. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 31(5), 554-7. PMID: 20334551.

Pfaller, M. A., Castanheira, M., Diekema, D. J., Messer, S. A., Moet, G. J. & Jones, R. N. (2010). Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. Journal of clinical microbiology, 48(5), 1592-9. PMID: 20335424.

Endimiani, A., Hujer, A. M., Perez, F., Bethel, C. R., Hujer, K. M., Kroeger, J., Oethinger, M., Paterson, D. L., Adams, M. D., Jacobs, M. R., Diekema, D. J., Hall, G. S., Jenkins, S. G., Rice, L. B., Tenover, F. C. & Bonomo, R. A. (2009). Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. The Journal of antimicrobial chemotherapy, 63(3), 427-37. PMID: 19155227.

Morgan, D. J., Diekema, D. J., Sepkowitz, K. & Perencevich, E. N. (2009). Adverse outcomes associated with Contact Precautions: a review of the literature. American journal of infection control, 37(2), 85-93. PMID: 19249637.

Lockhart, S. R., Messer, S. A., Gherna, M., Bishop, J. A., Merz, W. G., Pfaller, M. A. & Diekema, D. J. (2009). Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. Journal of clinical microbiology, 47(4), 1216-7. PMID: 19193845.

Lockhart, S. R., Messer, S. A., Pfaller, M. A. & Diekema, D. J. (2009). Identification and Susceptibility Profile of Candida fermentati from a worldwide collection of Candida guilliermondii clinical isolates. Journal of clinical microbiology, 47(1), 242-4. PMID: 19036938.

Klevay, M. J., Horn, D. L., Neofytos, D., Pfaller, M. A. & Diekema, D. J. (2009). Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagnostic microbiology and infectious disease, 64(2), 152-7. PMID: 19376667.

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Bijie, H., Dzierzanowska, D., Klimko, N. N., Letscher-Bru, V., Lisalova, M., Muehlethaler, K., Rennison, C. & Zaidi, M. (2009). Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. Journal of clinical microbiology, 47(1), 117-23. PMID: 19005141.

Smith, T. C., Male, M. J., Harper, A. L., Kroeger, J. S., Tinkler, G. P., Moritz, E. D., Capuano, A. W., Herwaldt, L. A. & Diekema, D. J. (2009). Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers. PloS one, 4(1), e4258. PMID: 19145257.

Wyatt, C., Winokur, P., Page, J., Von Stein, D. & Diekema, D. J. (2009). Differing acquisition rates of MRSA and VRE during an active surveillance-contact precautions intervention.

Diekema, D., Perencevich, E., Babcock, H. & Edmond, M. (2009). Controversies in hospital infection prevention: pondering vexing issues in infection prevention.

Pottinger, J., Steelman, V., Schlueter, A., Chiang, H. Y., Diekema, D. J. & Herwaldt, L. (2009). Clinical significance of positive cranial bone flap cultures, and risk of surgical site infection post-craniotomy.

Diekema, D. J., Messer, S. A., Hollis, R. J., Boyken, L., Tendolkar, S., Kroeger, J., Jones, R. N. & Pfaller, M. A. (2009). A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. Diagnostic microbiology and infectious disease, 63(2), 233-6. PMID: 19070452.

Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2009). In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method. Journal of clinical microbiology, 47(10), 3323-5. PMID: 19710267.

Diekema, D. J., Messer, S. A., Boyken, L. B., Hollis, R. J., Kroeger, J., Tendolkar, S. & Pfaller, M. A. (2009). In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. Journal of clinical microbiology, 47(10), 3170-7. PMID: 19710283.

Van De Griend, P., Herwaldt, L. A., Alvis, B., DeMartino, M., Heilmann, K., Doern, G., Winokur, P., Vonstein, D. D. & Diekema, D. (2009). Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA. Emerging infectious diseases, 15(10), 1582-9. PMID: 19861049.

Etienne, K. A., Gade, L., Lockhart, S. R., Diekema, D. J., Messer, S. A., Pfaller, M. A. & Balajee, S. A. (2009). Screening of a large global Aspergillus fumigatus species complex collection by using a species-specific microsphere-based Luminex assay. Journal of clinical microbiology, 47(12), 4171-2. PMID: 19794043.

Pfaller, M. A., Messer, S. A., Georgopapadakou, N., Martell, L. A., Besterman, J. M. & Diekema, D. J. (2009). Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens. Journal of clinical microbiology, 47(12), 3797-804. PMID: 19794038.

Siikala, E., Richardson, M., Pfaller, M. A., Diekema, D. J., Messer, S. A., Perheentupa, J., Saxén, H. & Rautemaa, R. (2009). Candida albicans isolates from APECED patients show decreased susceptibility to miconazole. International journal of antimicrobial agents, 34(6), 607-9. PMID: 19748230.

Pfaller, M. A., Diekema, D. J., Ghannoum, M. A., Rex, J. H., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Espinel-Ingroff, A., Fowler, C. L., Johnson, E. M., Knapp, C. C., Motyl, M. R., Ostrosky-Zeichner, L., Sheehan, D. J. & Walsh, T. J. (2009). Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. Journal of clinical microbiology, 47(10), 3142-6. PMID: 19692559.

Reighard, A., Diekema, D., Wibbenmeyer, L., Ward, M. & Herwaldt, L. (2009). Staphylococcus aureus nasal colonization and colonization or infection at other body sites in patients on a burn trauma unit. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 30(8), 721-6. PMID: 19580438.

Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2009). Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program. Diagnostic microbiology and infectious disease, 65(1), 27-34. PMID: 19679232.

Pfaller, M. A., Messer, S. A., Hollis, R. J., Boyken, L., Tendolkar, S., Kroeger, J. & Diekema, D. J. (2009). Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. Journal of clinical microbiology, 47(10), 3185-90. PMID: 19656983.

Andrews, J. I., Fleener, D. K., Messer, S. A., Kroeger, J. S. & Diekema, D. J. (2009). Screening for Staphylococcus aureus carriage in pregnancy: usefulness of novel sampling and culture strategies. American journal of obstetrics and gynecology, 201(4), 396.e1-5. PMID: 19716114.

Polgreen, P. M., Beekmann, S. E., Diekema, D. J. & Sherertz, R. J. (2008). Antimicrobial lock therapy and prophylaxis practice patterns: An Emerging Infections Network Survey.

Diekema, D. J., Messer, S. A., Hollis, R. J., Kroeger, J., Boyken, L., Tendolkar, S. & Pfaller, M. A. (2008). Antifungal Activity Against a Large Global Collection of Rare Candida Species.

Diekema, D. J., Messer, S. A., Besterman, J. & Pfaller, M. A. (2008). Combination Testing of MGCD290, a Fungal Histone Deacetylase Inhibitor, with Azole Antifungals against a Large Collection of Clinical Fungal Isolates.

Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2008). In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. Journal of clinical microbiology, 46(1), 150-6. PMID: 18032613.

Lockhart, S. R., Messer, S. A., Pfaller, M. A. & Diekema, D. J. (2008). Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections. Journal of clinical microbiology, 46(1), 374-6. PMID: 17959765.

Wibbenmeyer, L. A., Kealey, G. P., Latenser, B. A., Diekema, D. J., Williams, I. M., Coffman, S. L., Winokur, P. L., Kroeger, J. S., Lewis, R. W. & Herwaldt, L. A. (2008). Emergence of the USA300 strain of methicillin-resistant Staphylococcus aureus in a burn-trauma unit. Journal of burn care & research : official publication of the American Burn Association, 29(5), 790-7. PMID: 18695604.

Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2008). Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program. Journal of clinical microbiology, 46(2), 551-9. PMID: 18094129.

Reighard, A., Diekema, D. J., Wibbenmeyer, L., Ward, M. & Herwaldt, L. A. (2008). Staphylococcus aureus colonization and infection on a burn/trauma unit.

Klevay, M. J., Horn, D., Neofytos, D., Pfaller, M. A. & Diekema, D. J. (2008). Empiric Treatment and Outcome of Candida glabrata versus C. albicans Bloodstream Infection.

Lockhart, S. J., Diekema, D. J. & Pfaller, M. A. (2008). The epidemiology of fungal infections.

Diekema, D. J., Messer, S. A., Hollis, R. J., Kroeger, J., Boyken, L., Tendolkar, S., Lockhart, S., Jones, R. N. & Pfaller, M. A. (2008). Voriconazole Activity Against Aspergillus spp: Eight Years of Global Surveillance.

Andes, D., Diekema, D. J., Pfaller, M. A., Prince, R. A., Marchillo, K., Ashbeck, J. & Hou, J. (2008). In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. Antimicrobial agents and chemotherapy, 52(2), 539-50. PMID: 18070979.

Klevay, M. J., Diekema, D. J. (2008). Response to letter to the editor. Diagn Microbiol Infect Dis, 61, 364.

Pfaller, M. A., Diekema, D. J. & Merz, W. G. (2008). Infections caused by non-Candida, non-Cryptococcis yeasts.

Pfaller, M. A., Messer, S. A., Kroeger, J., Boyken, L., Tendolkar, S., Hollis, R. & Diekema, D. J. (2008). Reading Fluconazole Susceptibility after 24 Hours: Validation against the Clinical and Laboratory Standards Institute (CLSI) Reference Methods.

Klevay, M. J., Coffman, S. L., David, S. A., Lockhart, S. R., Latenser, B. A., Heile, J. A., Herwaldt, L. a. & Diekema, D. J. (2008). A cluster of Aspergillus flavus wound infections in a burn unit.

Lockhart, S. R., Messer, S. A., Pfaller, M. A. & Diekema, D. J. (2008). Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. Journal of clinical microbiology, 46(8), 2659-64. PMID: 18562582.

Wrobel, L., Whittington, J. K., Pujol, C., Oh, S. H., Ruiz, M. O., Pfaller, M. A., Diekema, D. J., Soll, D. R. & Hoyer, L. L. (2008). Molecular phylogenetic analysis of a geographically and temporally matched set of Candida albicans isolates from humans and nonmigratory wildlife in central Illinois. Eukaryotic cell, 7(9), 1475-86. PMID: 18621922.

Pfaller, M. A., Diekema, D. J., Ostrosky-Zeichner, L., Rex, J. H., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C., Sheehan, D. J. & Walsh, T. J. (2008). Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. Journal of clinical microbiology, 46(8), 2620-9. PMID: 18579718.

Andrews, J. I., Shamshirsaz, A. A. & Diekema, D. J. (2008). Nonmenstrual toxic shock syndrome due to methicillin-resistant Staphylococcus aureus. Obstetrics and gynecology, 112(4), 933-8. PMID: 18827138.

Riedel, S., Von Stein, D., Richardson, K., Page, J., Miller, S., Winokur, P. & Diekema, D. (2008). Development of a prediction rule for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus carriage in a Veterans Affairs Medical Center population. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 29(10), 969-71. PMID: 18702599.

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Nagy, E., Dobiasova, S., Rinaldi, M., Barton, R. & Veselov, A. (2008). Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. Journal of clinical microbiology, 46(2), 515-21. PMID: 18077633.

Ostrosky-Zeichner, L., Rex, J. H., Pfaller, M. A., Diekema, D. J., Alexander, B. D., Andes, D., Brown, S. D., Chaturvedi, V., Ghannoum, M. A., Knapp, C. C., Sheehan, D. J. & Walsh, T. J. (2008). Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Antimicrobial agents and chemotherapy, 52(11), 4175-7. PMID: 18809944.

Andes, D. R., Diekema, D. J., Pfaller, M. A., Marchillo, K. & Bohrmueller, J. (2008). In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model. Antimicrobial agents and chemotherapy, 52(10), 3497-503. PMID: 18625768.

Diekema, D. J., Climo, M. (2008). Preventing MRSA infections: finding it is not enough. JAMA : the journal of the American Medical Association, 299(10), 1190-2. PMID: 18334697.

Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2008). In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species. Journal of clinical microbiology, 46(8), 2568-72. PMID: 18562581.

Klevay, M. J., Ernst, E. J., Hollanbaugh, J. L., Miller, J. G., Pfaller, M. A. & Diekema, D. J. (2008). Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagnostic microbiology and infectious disease, 60(3), 273-7. PMID: 18024053.

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ng, K. P., Colombo, A., Finquelievich, J., Barnes, R. & Wadula, J. (2008). Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. Journal of clinical microbiology, 46(3), 842-9. PMID: 18199791.

Huang, S. S., Diekema, D. J., Warren, D. K., Zuccotti, G., Winokur, P. L., Tendolkar, S., Boyken, L., Datta, R., Jones, R. M., Ward, M. A., Aubrey, T., Onderdonk, A. B., Garcia, C. & Platt, R. (2008). Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 46(8), 1241-7. PMID: 18444862.

Pfaller, M. A., Chaturvedi, V., Diekema, D. J., Ghannoum, M. A., Holliday, N. M., Killian, S. B., Knapp, C. C., Messer, S. A., Miskov, A. & Ramani, R. (2008). Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. Journal of clinical microbiology, 46(7), 2155-9. PMID: 18463213.

Diekema, D. (2008). Benefits and drawbacks of universal surveillance of methicillin-resistant Staphylococcus aureus. Annals of internal medicine, 149(1), 67; author reply 68-9. PMID: 18591646.

Andrews, J. I., Fleener, D. & Diekema, D. J. (2007). The Yeast Connection ? is Candida linked to breastfeeding associated pain?.

Lockhart, S. R., Messer, S. A., Tendolkar, S., Pfaller, M. A. & Diekema, D. J. (2007). Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis, in comparison to the closely-related species Candida parapsilosis.

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ng, K. P., Colombo, A. L., Finquelievich, J., Barnes, R. & Wadula, J. (2007). Geographic and temporal trends in the isolation and antifungal susceptibility of Candida parapsilosis: A global assessment from the ARTEMIS DISK Antifungal Surveillance Program.

Alamu, J., Diekema, D. J., Davis, P. & Herwaldt, L. A. (2007). Evaluation of antimicrobial use in a pediatric intensive care unit (PICU).

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Nagy, E., Dobiasova, S., Rinaldi, M., Barton, R. & Veselov, A. (2007). Candida krusei, a multidrug-resistant fungal pathogen: Geographical and temporal trends form the ARTEMIS DISK Antifungal Surveillance Program.

Van de Griend, P., Herwaldt, L. A., Alvis, B., Demartino, M., Heilmann, K., Doern, G. V., Winokur, P. L. & Diekema, D. J. (2007). Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA): An emerging cause of bloodstream infection (BSI) in Iowa.

Piehl, D., Diekema, D. J., Howard, W. & Andrews, J. I. (2007). Absence of vaginal methicillin-resistant Staphylococcus aureus (MRSA) carriage in the setting of increasing community associated MRSA rates.

Riedel, S., Von Stein, D., Miller, S., Page, J., Winokur, P. L. & Diekema, D. J. (2007). Identifying MRSA or VRE carriers in a Veterans Affairs Medical Center population.

Pfaller, M. A., Diekema, D. J. (2007). Azole antifungal drug cross-resistance: Resistance mechanisms, epidemiology, and clinical significance. J Invasive Fungal Infect, 1, 74-62.

Klevay, M. J., Ernst, E., Hollanbaugh, J. L., Miller, J. G., Pfaller, M. A. & Diekema, D. J. (2007). The epidemiology and impact of untreated candidemia.

Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2007). In vitro susceptibility of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance.

Patel, S., Diekema, D. J., Leung, J., Applegate, D., Winokur, P. L., Von Stein, D., Boyken, L., Kroeger, J. & Herwaldt, L. A. (2007). The epidemiology of MRSA at a university hospital in a rural state.

Klevay, M., Ernst, E., Miller, J., Hollanbaugh, J., Pfaller, M. A. & Diekema, D. J. (2007). The importance of appropriate therapy for candidemia.

Pfaller, M. A., Diekema, D. J., Andes, D., Rinaldi, M., Fothergill, A., Pappas, P., Lortholary, O., Mohr, J., Kovanda, L., Villmann, M. & Buell, D. (2007). A proposal for an antifungal susceptibility testing breakpoint for micafungin and Candida: Integration of AST surveys and correlation with clinical outcomes.

Diekema, D. J., Messer, S. A., Georgopapdakou, N. & Pfaller, M. A. (2007). Synergy of MG3290, a histone deacetylase inhibitor, with azoles tested against clinical isolates of Candida and Aspergillus.

Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Kroeger, J. & Diekema, D. J. (2007). Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida: Results from a global antifungal surveillance program.

Johannsson, B., Chen, Y. Y., Beekmann, S., Shamsuddin, H. H., Diekema, D. J., Herwaldt, L. & Polgreen, P. M. (2007). Methicillin susceptible Staphylococcus aureus bloodstream infection: Missed opportunities to optimize antimicrobial therapy.

Pfaller, M. A., Diekema, D. J., Procop, G. & Rinaldi, M. (2007). Multicenter comparison of the VITEK 2 Yeast Susceptibility Test with the CLSI broth microdilution method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.

Diekema, D. J., Messer, S. A., Hollis, R. J., Boyken, L., Tendolkar, S., Kroeger, J. & Pfaller, M. A. (2007). Patterns of cross-resistance/susceptibility among a large collection of clinical isolates of Aspergillus spp.

Huang, S. S., Rifas-Shiman, S. L., Warren, D. K., Fraser, V. J., Climo, M. W., Wong, E. S., Cosgrove, S. E., Perl, T. M., Pottinger, J. M., Herwaldt, L. A., Jernigan, J. A., Tokars, J. L., Diekema, D. J., Hinrichsen, V. L., Yokoe, D. S. & Platt, R. (2007). Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. The Journal of infectious diseases, 195(3), 330-8. PMID: 17205470.

Diekema, D. J., Edmond, M. B. (2007). Look before you leap: active surveillance for multidrug-resistant organisms. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 44(8), 1101-7. PMID: 17366459.

Diekema, D. J., Messer, S. A., Hollis, R. J., Boyken, L. B., Tendolkar, S., Kroeger, J. & Pfaller, M. A. (2007). Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole. Journal of clinical microbiology, 45(6), 1974-7. PMID: 17301284.

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Meis, J. F., Gould, I. M., Fu, W., Colombo, A. L. & Rodriguez-Noriega, E. (2007). Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. Journal of clinical microbiology, 45(6), 1735-45. PMID: 17442797.

Messer, S. A., Diekema, D. J., Hollis, R. J., Boyken, L. B., Tendolkar, S., Kroeger, J. & Pfaller, M. A. (2007). Evaluation of disk diffusion and Etest compared to broth microdilution for antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi. Journal of clinical microbiology, 45(4), 1322-4. PMID: 17267623.

Flanagan, M., Ramanujam, R., Sutherland, J., Vaughn, T., Diekema, D. & Doebbeling, B. N. (2007). Development and validation of measures to assess prevention and control of AMR in hospitals. Medical care, 45(6), 537-44. PMID: 17515781.

Andrews, J. I., Fleener, D. K., Messer, S. A., Hansen, W. F., Pfaller, M. A. & Diekema, D. J. (2007). The yeast connection: is Candida linked to breastfeeding associated pain?. American journal of obstetrics and gynecology, 197(4), 424.e1-4. PMID: 17904988.

Knapp, C. C., Holliday, N., Miskov, A., Killian, S. B., Ghannoum, M. A., Pfaller, M. A., Messer, S. A., Diekema, D. J. & Chaturvedi, V. (2007). A multi-site evaluation of two new echinocandins anidulafungin, and micafungin on a colorimetric MIC susceptibility test plate compared with the CLSI M27 reference broth microdilution (BMD) plate for antifungal susceptibility testing.

Zhao, X., Oh, S. H., Jajko, R., Diekema, D. J., Pfaller, M. A., Pujol, C., Soll, D. R. & Hoyer, L. L. (2007). Analysis of ALS5 and ALS6 allelic variability in a geographically diverse collection of Candida albicans isolates. Fungal genetics and biology : FG & B, 44(12), 1298-309. PMID: 17625934.

Lockhart, S. R., Abramson, M. A., Beekmann, S. E., Gallagher, G., Riedel, S., Diekema, D. J., Quinn, J. P. & Doern, G. V. (2007). Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. Journal of clinical microbiology, 45(10), 3352-9. PMID: 17715376.

Pfaller, M. A., Diekema, D. J., Procop, G. W. & Rinaldi, M. G. (2007). Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. Journal of clinical microbiology, 45(11), 3522-8. PMID: 17913927.

Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2007). Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods. Journal of clinical microbiology, 45(1), 70-5. PMID: 17079501.

Von Stein, D., Diekema, D. J., Richardson, K., Page, J., Riedel, S., Miller, S. & Winokur, P. L. (2007). "Real-life" performance of real-time PCR for detection of MRSA and VRE.

Pfaller, M. A., Diekema, D. J., Procop, G. W. & Rinaldi, M. G. (2007). Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. Journal of clinical microbiology, 45(3), 796-802. PMID: 17215344.

Song, X., Yokoe, D., Platt, R., Herwaldt, L. A., Diekema, D. J., Zuccotti, G., Plaskett, T., Wong, E., Climo, M., Cosgrove, S. & Perl, T. (2007). A multi-site assessment of an antimicrobial and diagnosis code-based screening tool to detect surgical site infections following craniotomy.

Hollanbaugh, J. L., Ernst, E., Klevay, M. J., Ngo, N., Miller, J. G., Pfaller, M. A. & Diekema, D. J. (2007). A case-case-control study of antimicrobial use and other risk factors for candidemia.

Diekema, D. J. (2007). Healthcare-associated fungal infections: beyond Candida and Aspergillus. Southern medical journal, 100(2), 130-1. PMID: 17330678.

Pfaller, M. A., Diekema, D. J. (2007). Epidemiology of invasive candidiasis: a persistent public health problem. Clinical microbiology reviews, 20(1), 133-63. PMID: 17223626.

Polgreen, P. M., Chen, Y. Y., Cavanaugh, J. E., Ward, M., Coffman, S., Hornick, D. B., Diekema, D. J. & Herwaldt, L. A. (2007). An outbreak of severe Clostridium difficile-associated disease possibly related to inappropriate antimicrobial therapy for community-acquired pneumonia. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 28(2), 212-4. PMID: 17265406.

Huang, S. S., Rifas-Shiman, S. L., Pottinger, J. M., Herwaldt, L. A., Zembower, T. R., Noskin, G. A., Cosgrove, S. E., Perl, T. M., Curtis, A. B., Tokars, J. L., Diekema, D. J., Jernigan, J. A., Hinrichsen, V. L., Yokoe, D. S. & Platt, R. (2007). Improving the assessment of vancomycin-resistant enterococci by routine screening. The Journal of infectious diseases, 195(3), 339-46. PMID: 17205471.

Diekema, D. J., Messer, S. A., Boyken, L., Tendolkar, S., Kroeger, J., Hollis, R. & Pfaller, M. A. (2006). Candida glabrata: Five years of sentinel antifungal resistance surveillance.

Ernst, E., Ngo, N., Miller, J., Klevay, M., Jepson, R., Pfaller, M. A. & Diekema, D. J. (2006). Antimicrobial usage in C. glabrata and C. albicans bloodstream infection.

Diekema, D. J., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S. & Pfaller, M. A. (2006). Anidulafungin activity against invasive clinical isolates of Candida: Relationship to fluconazole susceptibility.

Polgreen, P. M., Diekema, D. J., Vandeberg, J., Wiblin, R. T., Chen, Y. Y., David, S., Rasmus, D., Gerdts, N., Ross, A., Katz, L. & Herwaldt, L. A. (2006). Risk factors for groin wound infection after femoral artery catheterization: a case-control study. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 27(1), 34-7. PMID: 16418984.

Pfaller, M. A., Diekema, D. J., Mendez, M., Kibbler, C., Erzsebet, P., Chang, S., Gibbs, D. & Newell, V. (2006). Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: Global surveillance from the ARTEMIS disk antifungal surveillance program.

Herwaldt, L. A., Latenser, B. A., Wibbenmeyer, L., Coffman, S., Winokur, P. L. & Diekema, D. J. (2006). "Miliary" infections caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in a Burn Center.

Diekema, D. J., Messer, S. A., Hollis, R. J., Boyken, L., Tendolkar, S., Kroeger, J. & Pfaller, M. A. (2006). Evaluation of Etest and disk diffusion methods compared to broth microdilution antifungal susceptibility testing of posaconazole against clinical isolates of Candida.

Kuntz, J., Herwaldt, L. A., Applegate, D. M., Ward, M., Chen, Y. Y., Diekema, D. J. & Polgreen, P. M. (2006). Clostridium difficile associated disease among patients in a small rural hospital.

Polgreen, P. M., Pottinger, J., Polgreen, L., Diekema, D. J. & Herwaldt, L. A. (2006). Influenza vaccination rates, feedback and the Hawthorne effect. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 27(1), 98-9. PMID: 16528865.

Herwaldt, L. A., Schultz-Stubner, S., Kuntz, J. & Diekema, D. J. (2006). Infection control practices among anesthesia providers (APs) in the 7 CDC prevention epicenter hospitals.

Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J., Tendolkar, S., Kroeger, J. & Pfaller, M. A. (2006). In vitro activity of caspofungin against rare Candida species.

Messer, S., Diekema, D. J., Hollis, R. J., Boyken, L., Tendolkar, S., Kroeger, J. & Pfaller, M. A. (2006). Evaluation of disk diffusion and Etest compared to broth microdilution antifungal susceptibility testing of posaconazole against clinical isolates of filamentous fungi.

Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S., Tendolkar, S. & Diekema, D. J. (2006). Global Surveillance of the in vitro activity of micafungin against Candida: A comparison with caspofungin using Clinical and Laboratory Standards Institute recommended methods.

Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2006). Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods. Journal of clinical microbiology, 44(10), 3533-8. PMID: 17021079.

Messer, S. A., Diekema, D. J., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2006). Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. Journal of clinical microbiology, 44(2), 324-6. PMID: 16455878.

Pfaller, M. A., Diekema, D. J., Colombo, A. L., Kibbler, C., Ng, K. P., Gibbs, D. L. & Newell, V. A. (2006). Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. Journal of clinical microbiology, 44(10), 3578-82. PMID: 17021085.

Pfaller, M. A., Diekema, D. J., Mendez, M., Kibbler, C., Erzsebet, P., Chang, S. C., Gibbs, D. L. & Newell, V. A. (2006). Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. Journal of clinical microbiology, 44(10), 3551-6. PMID: 17021081.

Zillich, A. J., Sutherland, J. M., Wilson, S. J., Diekema, D. J., Ernst, E. J., Vaughn, T. E. & Doebbeling, B. N. (2006). Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 27(10), 1088-95. PMID: 17006817.

Ernst, E., Miller, J., Jepson, R., Klevay, M., Pfaller, M. A. & Diekema, D. J. (2006). Risk factors for Candida glabrata bloodstream infection: A case-control study.

Neofytos, D., Pfaller, M. A., Diekema, D. J. & Horn, D. (2006). A case of recurrent episodes of Candida parapsilosis fungemia. Mycopathologia, 162(4), 295-8. PMID: 17039276.

Sigurdardottir, B., Berg, J. V., Hu, J., Alamu, J., McNutt, L. A., Diekema, D. J. & Herwaldt, L. A. (2006). Descriptive epidemiology and case-control study of patients colonized with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 27(9), 913-9. PMID: 16941315.

Warren, D. K., Cosgrove, S. E., Diekema, D. J., Zuccotti, G., Climo, M. W., Bolon, M. K., Tokars, J. I., Noskin, G. A., Wong, E. S., Sepkowitz, K. A., Herwaldt, L. A., Perl, T. M., Solomon, S. L. & Fraser, V. J. (2006). A multicenter intervention to prevent catheter-associated bloodstream infections. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 27(7), 662-9. PMID: 16807839.

Polgreen, P. M., Beekmann, S. E., Chen, Y. Y., Doern, G. V., Pfaller, M. A., Brueggemann, A. B., Herwaldt, L. A. & Diekema, D. J. (2006). Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 27(3), 252-6. PMID: 16532412.

Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2006). In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance. Journal of clinical microbiology, 44(3), 760-3. PMID: 16517851.

Pfaller, M. A., Diekema, D. J., Rex, J. H., Espinel-Ingroff, A., Johnson, E. M., Andes, D., Chaturvedi, V., Ghannoum, M. A., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Troke, P., Walsh, T. J. & Warnock, D. W. (2006). Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. Journal of clinical microbiology, 44(3), 819-26. PMID: 16517860.

Pfaller, M. A., Diekema, D. J. & Sheehan, D. J. (2006). Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clinical microbiology reviews, 19(2), 435-47. PMID: 16614256.

Siwek, G. T., Pfaller, M. A., Polgreen, P. M., Cobb, S., Hoth, P., Magalheas-Silverman, M. & Diekema, D. J. (2006). Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. Diagnostic microbiology and infectious disease, 55(3), 209-12. PMID: 16626917.

Beekmann, S. E., Diekema, D. J., Heilmann, K. P., Richter, S. S. & Doern, G. V. (2006). Macrolide use identified as risk factor for macrolide-resistant Streptococcus pneumoniae in a 17-center case-control study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 25(5), 335-9. PMID: 16612609.

Polgreen, P. M., Diekema, D. J., Applegate, D. M., Chen, Y. Y., Killgore, G. E., Kuntz, J., Messer, S. A., Thompson, A., Vande Berg, J. & Herwaldt, L. A. (2006). Risk factors for Clostridium difficile associated disease (CDAD) at a Midwestern teaching hospital.

Diekema, D. J., Pfaller, M. A. (2006). Infection control epidemiology and clinical microbiology.

Herwaldt, L. A., Applegate, D., Kuntz, J., Ward, M., Vande Berg, J., Wibbenmeyer, L. & Diekema, D. J. (2006). Risk factors for colonization with MRSA or VRE on a Burn and Wound Unit.

Huang, S. S., Diekema, D. J., Warren, D. K., Zuccotti, G., Winokur, P. L., Tendolkar, S., Boyken, L., Datta, R., Jones, R. N., Ward, M., Aubrey, T., Onderdonk, A. & Platt, R. (2006). Strain relatedness of isolates from patients with serial methicillin-resistant Staphylococcus aureus infection.

Messer, S., Diekema, D. J., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). Evaluation of the CLSI M44-A Disk Diffusion Method for Determining Susceptibilities of 584 Clinical Isolates of Cryptococcus neoformans to Voriconazole.

Alvis, B., Diekema, D. J., Messer, S. A., Boyken, L. & Tendolkar, S. (2005). Evaluation of the Disk Diffusion Method Compared to Broth Microdilution Antifungal Susceptibility Testing of Voriconazole against Clinical Isolates of Filamentous Fungi.

Cosgrove, S. E., Srinivasan, A., Seo, S. K., Bolon, M. K., Climo, M., Diekema, D. J., Speck, K., Gase, K., Moskin, G., Herwaldt, L. A., Wong, E., Song, X., Curtis, A., Solomon, S., Tokars, J. I. & Perl, T. M. (2005). Evaluation of post-prescription review as a model of promoting rational antimicrobial use: A multi-center study.

Alvis, B., Diekema, D. J., Messer, S. A., Boyken, L., Tendolkar, S. & Pfaller, M. A. (2005). Evaluation of the Disk Diffusion Method Compared to Broth Microdilution Antifungal Susceptibility Testing of Voriconazole against Clinical Isolates of Filamentous Fungi.

Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2005). Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program.

Diekema, D. J., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). In vitro Activity of Caspofungin against Invasive Clinical Isolates of Candida: Four Years of Sentinel Surveillance.

Miller, R. A., Park, B. J., Fridkin, S. K., Morrison, V. A., Pappas, P. G., Alexander, B., Schuster, M. & Diekema, D. J. (2005). Characterization of very late onset invasive aspergillosis (IA) among organ transplant recipients.

Miller, R. A., Park, B. J., Fridkin, S. K., Morrison, V. A., Pappas, P. G., Alexander, B., Schuster, M. & Diekema, D. J. (2005). Characterization of very late onset invasive aspergillosis (IA) among organ transplant recipients.

Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2005). Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program.

Diekema, D. J., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). In vitro Activity of Caspofungin against Invasive Clinical Isolates of Candida: Four Years of Sentinel Surveillance.

Wilson, D. J., Sutherland, J. M. & Diekema, D. J. (2005). Characteristics and outcomes of US hospitals that perform active surveillance for methicillin-resistant Staphylococcus aureus: Results of a large, national survey.

Polgreen, P. M., Diekema, D. J., Herwaldt, L. A., Cavanaugh, J. E., Nelson, F. D. & Neumann, G. R. (2005). The use of a prediction market to forecast influenza activity.

Polgreen, P. M., Diekema, D. J., Herwaldt, L. A., Cavanaugh, J. E. & Nelson, F. D. (2005). The use of a prediction market to forecast influenza activity.

Diekema, D. J., Pfaller, M. A. Infection Control Epidemiology and Clinical Microbiology. In Manual of Clinical Microbiology, 10th Edition. pp. 73-84. American Society for Microbiology. DOI: 10.1128/9781555816728.ch6.

Diekema, D. J., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). Prospective Global Surveillance for Candida spp. Infection: Four Year Results from the ARTEMIS Study.

Diekema, D. J., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). Prospective Global Surveillance for Candida spp. Infection: Four Year Results from the ARTEMIS Study.

Messer, S., Diekema, D. J., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). Micafungin Activity against 315 Invasive Clinical Isolates of Fluconazole Resistant Candida.

Messer, S., Diekema, D. J., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). Micafungin Activity against 315 Invasive Clinical Isolates of Fluconazole Resistant Candida.

Ince, D., Winokur, P., Beekmann, S., Herwaldt, L. A., Pfaller, M. A., Doern, G. V. & Diekema, D. J. (2005). Prevalence of Panton Valentine Leukocidin genes among methicillin-resistant Staphylococcus aureus in Iowa.

Messer, S., Diekema, D. J., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). Evaluation of the CLSI M44-A Disk Diffusion Method for Determining Susceptibilities of 584 Clinical Isolates of Cryptococcus neoformans to Voriconazole.

Beekmann, S. E., Diekema, D. J. & Doern, G. V. (2005). Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 26(6), 559-66. PMID: 16018432.

Sohn, S., Climo, M., Diekema, D., Fraser, V., Herwaldt, L., Marino, S., Noskin, G., Perl, T., Song, X., Tokars, J., Warren, D., Wong, E., Yokoe, D. S., Zembower, T. & Sepkowitz, K. A. (2005). Varying rates of Clostridium difficile-associated diarrhea at prevention epicenter hospitals. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 26(8), 676-9. PMID: 16156322.

Klevay, M., Ebinger, A., Diekema, D., Messer, S., Hollis, R. & Pfaller, M. (2005). Disk diffusion testing using Candida sp. colonies taken directly from CHROMagar Candida medium may decrease time required to obtain results. Journal of clinical microbiology, 43(7), 3497-9. PMID: 16000489.

Ernst, E. J., Raley, G., Herwaldt, L. A. & Diekema, D. J. (2005). Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 26(7), 634-7. PMID: 16092744.

Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2005). In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods. Journal of clinical microbiology, 43(8), 3807-10. PMID: 16081915.

Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2005). Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program. Journal of clinical microbiology, 43(10), 5208-13. PMID: 16207985.

Pfaller, M. A., Diekema, D. J. & Rinaldi, M. G. (2005). Antifungal drugs: Mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biologic fluids. In V. Lorian (Eds.) Antibiotics in Laboratory Medicine. (5), pp. 226-265. Philadelphia, PA: Lippincott Williams & Wilkins.

Wilson, D. J., Sutherland, J. M. & Diekema, D. J. (2005). Characteristics and outcomes of US hospitals that perform active surveillance for methicillin-resistant Staphylococcus aureus.

Pfaller, M. A., Diekema, D. J., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J. & Goldstein, B. P. (2005). Effectiveness of anidulafungin in eradicating Candida species in invasive candidiasis. Antimicrobial agents and chemotherapy, 49(11), 4795-7. PMID: 16251335.

Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2005). In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. Journal of clinical microbiology, 43(11), 5425-7. PMID: 16272464.

Pfaller, M. A., Diekema, D. J., Rinaldi, M. G., Barnes, R., Hu, B., Veselov, A. V., Tiraboschi, N., Nagy, E. & Gibbs, D. L. (2005). Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. Journal of clinical microbiology, 43(12), 5848-59. PMID: 16333066.

Flach, S. D., Diekema, D. J., Yankey, J. W., BootsMiller, B. J., Vaughn, T. E., Ernst, E. J., Ward, M. M. & Doebbeling, B. N. (2005). Variation in the use of procedures to monitor antimicrobial resistance in U.S. hospitals. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 26(1), 31-8. PMID: 15693406.

Diekema, D. J., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). Activity of New and Investigational Antifungal Agents against Recent Clinical Isolates of Filamentous Fungi.

Diekema, D. J., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Pfaller, M. A. (2005). Activity of New and Investigational Antifungal Agents against Recent Clinical Isolates of Filamentous Fungi.

Richter, S. S., Galask, R. P., Messer, S. A., Hollis, R. J., Diekema, D. J. & Pfaller, M. A. (2005). Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. Journal of clinical microbiology, 43(5), 2155-62. PMID: 15872235.

Polgreen, P. M., Chen, Y. Y., Ward, M. M., Coffman, S., Diekema, D. J., Hornick, D. & Herwaldt, L. A. (2005). An outbreak of C. difficile-associated diarrhea among elderly patients in a small rural hospital.

Ward, M. M., Diekema, D. J., Yankey, J. W., Vaughn, T. E., BootsMiller, B. J., Pendergast, J. F. & Doebbeling, B. N. (2005). Implementation of strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in U.S. hospitals. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 26(1), 21-30. PMID: 15693405.

Pfaller, M. A., Diekema, D. J. (2005). Unusual fungal and pseudofungal infections of humans. Journal of clinical microbiology, 43(4), 1495-504. PMID: 15814958.

Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., Doern, G. V. & Diekema, D. J. (2005). Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). Journal of clinical microbiology, 43(5), 2163-7. PMID: 15872236.

Diekema, D. J., Petroelje, B., Messer, S. A., Hollis, R. J. & Pfaller, M. A. (2005). Activities of available and investigational antifungal agents against rhodotorula species. Journal of clinical microbiology, 43(1), 476-8. PMID: 15635020.

Pfaller, M. A., Richter, S. S. & Diekema, D. J. (2004). Conventional methods for the laboratory diagnosis of fungal infections in the immunocompromised host.

Klevay, M. J., Ebinger, A., Diekema, D. J., Messer, S., Hollis, R. J. & Pfaller, M. A. (2004). Disk diffusion testing of Candida inoculated directly from CHROMagar Candida medium may decrease time to results reporting.

Pfaller, M. A., Pujol, C., Diekema, D. J., Messer, S., Hollis, R. J. & Soll, D. R. (2004). Animal isolates of Candida albicans are not a source of resistance to common antifungal agents.

Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2004). Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of Candida spp. and Cryptococcus neoformans.

Pfaller, M. A., Hazen, K. C., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. & Diekema, D. J. (2004). Accuracy of Fluconazole Disk Testing for Candida Species: Comparison of participant results with results from a central reference laboratory in the ARTEMIS Global Antifungal Surveillance Program.

Sigurdardottir, B., Dodgson, K., Coffman, S., Howard, W., Vande Berg, J., Doern, G. V., Pfaller, M. A., Herwaldt, L. A. & Diekema, D. J. (2004). Effect of real-time PCR detection of vancomycin-resistant enterococci (VRE) on time to detection of colonized patients.

Diekema, D. J., Petroelje, B., Messer, S. A., Hollis, R. J. & Pfaller, M. A. (2004). Activity of available and investigational antifungal agents against Rhodotorula species.

Polgreen, P. M., Diekema, D. J., Herwaldt, L. A., Neumann, G. & Nelson, F. (2004). Institutional factors associated with a novel antimicrobial resistance index.

Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2004). Evaluation of the Etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for Candida species.

Sohn, S., Climo, M., Diekema, D. J., Fraser, V., Herwaldt, L. A., Marino, S., Noskin, G., Perl, T. M., Song, X., Tokars, J., Warren, D., Wong, E., Yokoe, D., Zembower, T. & Sepkowitz, K. A. (2004). Varying rates of Clostridium difficile diarrhea at Prevention Epicenter hospitals.

Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2004). Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole. Journal of clinical microbiology, 42(1), 380-3. PMID: 14715784.

Beekmann, S. E., Diekema, D. J., Chapin, K. C. & Doern, G. V. (2004). The optimal algorithm for determining the clinical significance of coagulase-negative Staphylococci (CNS) and other common skin contaminants (CSC).

Warren, D., Christian, L., Osa-Edoh, O., Climo, C., Wong, E., Cunningham, S. M., Noskin, G., Zuccotti, G., Plaskett, T., Tokars, J., Solomon, S. L., Cosgrove, S. E., Perl, T. M., Yokoe, D. S., Diekema, D. J., Herwaldt, L. A. & Fraser, V. J. (2004). The impact of an educational intervention on healthcare worker knowledge of catheter-associated bloodstream infections.

Dodgson, K. J., Stence, A. A., Diekema, D. J., Pfaller, M. A. & Doern, G. V. (2004). Implementation of a real-time PCR assay for VRE directly from peri-rectal swabs.

Polgreen, P. M., Pottinger, J., Diekema, D. J., Person, C., Coffman, S., Hartley, P. & Herwaldt, L. a. (2004). Influenza vaccination rates and the Hawthorne Effect: Increasing healthcare worker vaccination rates using "half-time" appraisals and targeted interventions including performance feedback.

Wilson, D. J., Yankey, J., Vaughn, T., Diekema, D. J., Flach, S. D., Ward, M. & Doebbeling, B. (2004). Institutional factors associated with a novel antimicrobial resistance index.

Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2004). Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp. Journal of clinical microbiology, 42(7), 3137-41. PMID: 15243072.

Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2004). Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates. Journal of clinical microbiology, 42(7), 3117-9. PMID: 15243069.

Siwek, G. T., Dodgson, K. J., de Magalhaes-Silverman, M., Bartelt, L. A., Kilborn, S. B., Hoth, P. L., Diekema, D. J. & Pfaller, M. A. (2004). Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 39(4), 584-7. PMID: 15356827.

Diekema, D. J., Pfaller, M. A. (2004). Nosocomial candidemia: an ounce of prevention is better than a pound of cure. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 25(8), 624-6. PMID: 15357151.

Yokoe, D. S., Noskin, G. A., Cunnigham, S. M., Zuccotti, G., Plaskett, T., Fraser, V. J., Olsen, M. A., Tokars, J. I., Solomon, S., Perl, T. M., Cosgrove, S. E., Tilson, R. S., Greenbaum, M., Hooper, D. C., Sands, K. E., Tully, J., Herwaldt, L. a., Diekema, D. J., Wong, E. S., Climo, M. & Platt, R. (2004). Enhanced identification of postoperative infections among inpatients. Emerging infectious diseases, 10(11), 1924-30. PMID: 15550201.

Pfaller, M. A., Diekema, D. J. (2004). Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. Journal of clinical microbiology, 42(10), 4419-31. PMID: 15472288.

Diekema, D. J., BootsMiller, B. J., Vaughn, T. E., Woolson, R. F., Yankey, J. W., Ernst, E. J., Flach, S. D., Ward, M. M., Franciscus, C. L., Pfaller, M. A. & Doebbeling, B. N. (2004). Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 38(1), 78-85. PMID: 14679451.

Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2004). Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species. Journal of clinical microbiology, 42(11), 4977-9. PMID: 15528683.

Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S. & Diekema, D. J. (2004). Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans. Diagnostic microbiology and infectious disease, 50(2), 113-7. PMID: 15474320.

Pfaller, M. A., Hazen, K. C., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2004). Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program. Journal of clinical microbiology, 42(8), 3607-12. PMID: 15297505.

Pfaller, M. A., Messer, S. A., Boyken, L., Hollis, R. J., Rice, C., Tendolkar, S. & Diekema, D. J. (2004). In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagnostic microbiology and infectious disease, 48(3), 201-5. PMID: 15023430.

Pfaller, M. A., Diekema, D. J. (2004). Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 10 Suppl 1, 11-23. PMID: 14748799.

Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2004). Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. Journal of clinical microbiology, 42(7), 3142-6. PMID: 15243073.

Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J. & Jones, R. N. (2004). In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagnostic microbiology and infectious disease, 48(2), 101-5. PMID: 14972378.

Pfaller, M. A., Boyken, L., Messer, S. A., Hollis, R. J. & Diekema, D. J. (2004). Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole. Journal of clinical microbiology, 42(3), 1288-9. PMID: 15004097.

Diekema, D. J., Dodgson, K. J., Sigurdardottir, B. & Pfaller, M. A. (2004). Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need. Journal of clinical microbiology, 42(7), 2879-83. PMID: 15243032.

Polgreen, P. M., Fultz, S. L., Justice, A. C., Wagner, J. H., Diekema, D. J., Rabeneck, L., Weissman, S. & Stapleton, J. T. (2004). Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people. HIV medicine, 5(3), 144-50. PMID: 15139979.

Ernst, E. J., Diekema, D. J., BootsMiller, B. J., Vaughn, T., Yankey, J. W., Flach, S. D., Ward, M. M., Franciscus, C. L., Acosta, E., Pfaller, M. A. & Doebbeling, B. N. (2004). Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?. Diagnostic microbiology and infectious disease, 49(2), 141-5. PMID: 15183864.

Diekema, D. J., Lee, K., Raney, P., Herwaldt, L. A., Doern, G. V. & Tenover, F. C. (2004). Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures. Journal of clinical microbiology, 42(5), 2258-60. PMID: 15131206.

Sigurdardottir, B., Diekema, D. J., Gillespie, S., Johnson, E., Vande Berg, J. & Herwaldt, L. (2003). Descriptive epidemiology of patients co-colonized with vancomycin-resistant Enterococcus spp. and methicillin-resistant Staphylococcus aureus.

Yankey, J., Diekema, D. J., Vaughn, T., Ernst, E., BootsMiller, B., Flach, S., Ward, M., Pendergast, J. & Doebbeling, B. N. (2003). Development and validation of a novel index to compare antimicrobial resistance across types of hospitals.

Ernst, E., Yankey, J., Diekema, D. J., Pfaller, M. A., BootsMiller, B., Vaughn, T. E., Ward, M., Flach, S., Franciscus, C., Acotsa, E. & Doebbeling, B. (2003). Are US Hospitals following National Guidelines for the Analysis and Presentation of Antibiogram Data?.

Warren, D., Osa-Edoh, O., Climo, M., Wong, E., Cunningham, S., Noskin, G., Zuccotti, G., Plaskett, T., Tokars, J., Solomon, S., Cosgrove, S., Perl, T., Diekema, D. J., Herwaldt, L. A. & Fraser, V. J. (2003). A multicenter intervention to prevent catheter-associated bloodstream infections in the ICU.

Doebbeling, B. N., Diekema, D. J., Vaughn, T., Yankey, J., BootsMiller, B., Flach, S., Ernst, E., Ward, M., Franciscus, C., Acosta, E. & Pfaller, M. (2003). Are US Hospitals following Antimicrobial Resistance Prevention and Control Guidelines?.

Diekema, D. J. (2003). Smallpox vaccinations. pp. A26. New York Times.

Pfaller, M. A., Messer, S. A., Boyken, L., Hollis, R. J., Rice, C., Tendolkar, S. & Diekema, D. J. (2003). Activities of voriconazole, posaconazole and fluconazole against 3,932 Candida species and 237 Cryptococcus neoformans: Report from the ARTEMIS Global Antifungal Surveillance Program, 2001-2002.

Diekema, D. J., BootsMiller, B., Ernst, E., Flach, S., Franciscus, C., Pfaller, M. A., Vaughn, T., Ward, M., Woolson, R., Yankey, J. & Doebbeling, B. (2003). Antimicrobial Resistance (AMR) Trends and Outbreak Frequency in United States Hospitals: Nationwide Surveys of Infection Control Professionals (ICPs) and Laboratory Directors (LDs).

Diekema, D. J. (2003). The clinician and the microbiology laboratory.

Flach, S. D., Yankey, J., Diekema, D. J., Vaughn, T., BootsMiller, B., Ward, M., Ernst, E. & Doebbeling, B. N. (2003). Hospitals' Use of Laboratory Procedures to Control Antimicrobial Resistance.

Andrew, J. I., Diekema, D. J. & Yankowitz, J. (2003). Prenatal testing for infectious diseases. Clin Lab Med, 4, 1-21.

Ernst, E., Raley, G., Herwaldt, L. A., Hu, J., Vandeberg, J. & Diekema, D. J. (2003). The Importance of Control Group Selection for Evaluating Antimicrobial Usage as a Risk Factor for Methicillin-Resistant Staphylococcus aureus Bacteremia.

Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J. & Jones, R. N. (2003). In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. Journal of clinical microbiology, 41(1), 78-83. PMID: 12517829.

Shamsuddin, H., Diekema, D. J. (2003). Opportunistic infections in hematopoetic transplant recipients.

Diekema, D. J., Pfaller, M. A. (2003). New antigungal agents. (Vols. 20). pp. 399. Infections in Medicine.

Pfaller, M. A., Hollis, R., Goldstein, B. P., Messer, S., Diekema, D. J. & Henkel, T. (2003). In Vitro activity of anidulafungin and other agents against 526 esophageal candidiasis isolates.

Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J. & Jones, R. N. (2003). In vitro susceptibilities of bloodstream isolates of rare Candida species against ravuconazole and three licensed antifungal agents.

Beekmann, S. E., Heilmann, K., Sauter, C., Diekema, D. J. & Doern, G. V. (2003). Methicillin-resistant S. aureus in Long-Term Care Facilities: Results from a Nationwide Surveillance Study.

Pfaller, M. A., Messer, S. A., Boyken, L., Hollis, R. J., Rice, C., Tendolkar, S. & Diekema, D. J. (2003). Evaluation of the NCCLS M44-P disk diffusion method for determining the fluconazole susceptibility of 276 clinical isolates of Cryptococcus neoformans.

Andrews, J. I., Diekema, D. J. & Yankowitz, J. (2003). Prenatal testing for infectious disease. Clinics in laboratory medicine, 23(2), 295-315, viii. PMID: 12848446.

Beekmann, S. E., Diekema, D. J., Chapin, K. C. & Doern, G. V. (2003). Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. Journal of clinical microbiology, 41(7), 3119-25. PMID: 12843051.

Diekema, D. J. (2003). Rapid response is best bet. pp. A20. Washington Post.

Diekema, D. J., Andrews, J. I., Huynh, H., Rhomberg, P. R., Doktor, S. R., Beyer, J., Shortridge, V. D., Flamm, R. K., Jones, R. N. & Pfaller, M. A. (2003). Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. Journal of clinical microbiology, 41(6), 2659-61. PMID: 12791897.

Diekema, D. J., Beekmann, S. E., Chapin, K. C., Morel, K. A., Munson, E. & Doern, G. V. (2003). Epidemiology and outcome of nosocomial and community-onset bloodstream infection. Journal of clinical microbiology, 41(8), 3655-60. PMID: 12904371.

Diekema, D. J., Messer, S. A., Hollis, R. J., Jones, R. N. & Pfaller, M. A. (2003). Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. Journal of clinical microbiology, 41(8), 3623-6. PMID: 12904365.

Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2003). Caspofungin activity against clinical isolates of fluconazole-resistant Candida. Journal of clinical microbiology, 41(12), 5729-31. PMID: 14662968.

Maxwell, M. J., Messer, S. A., Hollis, R. J., Diekema, D. J. & Pfaller, M. A. (2003). Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans. Journal of clinical microbiology, 41(1), 97-9. PMID: 12517832.

Climo, M., Diekema, D., Warren, D. K., Herwaldt, L. A., Perl, T. M., Peterson, L., Plaskett, T., Price, C., Sepkowitz, K., Solomon, S., Tokars, J., Fraser, V. J. & Wong, E. (2003). Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 24(12), 942-5. PMID: 14700410.

Gudlaugsson, O., Gillespie, S., Lee, K., Vande Berg, J., Hu, J., Messer, S., Herwaldt, L., Pfaller, M. & Diekema, D. (2003). Attributable mortality of nosocomial candidemia, revisited. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37(9), 1172-7. PMID: 14557960.

Diekema, D. J. (2003). Use of active surveillance cultures to control vancomycin-resistant Enterococcus. (Vols. 37). (10), pp. 1400-2; author reply 1402-3. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. PMID: 14583882.

Pfaller, M. A., Diekema, D. J., Messer, S. A., Hollis, R. J. & Jones, R. N. (2003). In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. Antimicrobial agents and chemotherapy, 47(3), 1068-71. PMID: 12604543.

Richter, S. S., Diekema, D. J., Heilmann, K. P., Almer, L. S., Shortridge, V. D., Zeitler, R., Flamm, R. K. & Doern, G. V. (2003). Fluoroquinolone resistance in Streptococcus pyogenes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 36(3), 380-3. PMID: 12539083.

Munson, E. L., Diekema, D. J., Beekmann, S. E., Chapin, K. C. & Doern, G. V. (2003). Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. Journal of clinical microbiology, 41(1), 495-7. PMID: 12517905.

Pfaller, M. A., Diekema, D. J., Boyken, L., Messer, S. A., Tendolkar, S. & Hollis, R. J. (2003). Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. Journal of clinical microbiology, 41(5), 1875-80. PMID: 12734220.

Pfaller, J. B., Messer, S. A., Hollis, R. J., Diekema, D. J. & Pfaller, M. A. (2003). In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. Journal of clinical microbiology, 41(3), 1126-9. PMID: 12624040.

Pfaller, M. A., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J. & Diekema, D. J. (2003). Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location. Journal of clinical microbiology, 41(5), 2176-9. PMID: 12734273.

Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L. & Hollis, R. J. (2003). Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. Journal of clinical microbiology, 41(4), 1440-6. PMID: 12682127.

Klepser, M. E., Klepser, D. G., Ernst, E. J., Brooks, J., Diekema, D. J., Mozaffari, E., Hendrickson, J. & Doern, G. V. (2003). Health care resource utilization associated with treatment of penicillin-susceptible and -nonsusceptible isolates of Streptococcus pneumoniae. Pharmacotherapy, 23(3), 349-59. PMID: 12627934.

Pfaller, M. A., Messer, S. A., Boyken, L., Hollis, R. J. & Diekema, D. J. (2003). In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs. Diagnostic microbiology and infectious disease, 45(4), 241-4. PMID: 12729993.

Maxwell, M. J., Messer, S. A., Hollis, R. J., Boyken, L., Tendolkar, S., Diekema, D. J. & Pfaller, M. A. (2003). Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood. Journal of clinical microbiology, 41(3), 1087-90. PMID: 12624034.

Pfaller, M. A., Messer, S. A., Boyken, L., Huynh, H., Hollis, R. J. & Diekema, D. J. (2002). In vitro activity of 5-flourocytosine (5-FC) against 6973 clinical isolates of Candida spp.: A global assessment of primary resistance using NCCLS susceptibility testing methods.

Pfaller, M. A., Diekema, D. J., Messer, S. A., Hollis, R. J. & Jones, R. N. (2002). In vitro activities of caspofungin compared with those of fluconaozole and itraconazole against 3959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.

Stapleton, J. T., Diekema, D. J. & Xiang, J. (2002). GB virus C and mortality from HIV infection. (Vols. 346). pp. 377. N Engl J Med.

Andrews, J. I., Diekema, D. J., Huynh, H., Rhomberg, P., Hollis, R. J., Jones, R. N. & Pfaller, M. A. (2002). Molecular Epidemiology of Macrolide Resistance among Group B Streptococci: Association of Macrolide Resistance with a Common PFGE Type of Serotype V.

Diekema, D. J., Messer, S. A., Hollis, R. J., Jones, R. N. & Pfaller, M. A. (2002). Five years of longitudinal global surveillance for Candida spp. infection: Stability of species distribution and fluconazole susceptibility from 1997-2001.

Diekema, D. J., Messer, S. A., Brueggemann, A. B., Coffman, S., Doern, G. V., Herwaldt, L. & Pfaller, M. A. (2002). The epidemiology of candidemia: Three-year results from the Emerging Infections and the Epidemiology of Iowa Organisms study.

Gudlaugsson, O., Gillespie, S., Lee, K., Vande Berg, J., Messer, S. A., Herwaldt, L., Pfaller, M. A. & Diekema, D. J. (2002). Nosocomial candidemia: Attributable mortality and excess length of stay revisited.

Maxwell, M. J., Messer, S. A., Hollis, R. J., Diekema, D. J. & Pfaller, M. A. (2002). Evaluation of Etest method for determining voriconazole and amphotericin B minimum inhibitory concentrations for 162 clinical isolates of Cryptococcus neoformans.

Beekmann, S. E., Diekema, D. J., Munson, E. & Doern, G. V. (2002). The specificity and positive predictive value of the NNIS definition for laboratory confirmed bloodstream infection with common skin contaminants.

Diekema, D. J., Pfaller, M. A. (2002). Role of the clinical microbiology laboratory in hospital epidemiology and infection control.

Climo, M., Diekema, D. J., Fraser, V. J., Hewaldt, L. A., Perl, T. M., Peterson, L. R., Plaskett, T., Price, C., Sepkowitz, K., Solomon, S., Tokars, J. & Wong, E. (2002). Prevalence of central line use in and outside the intensive care unit: Results of a survey among hospitals in the CDC's Prevention Epicenter Program.

Warren, D., Osa-Edoh, O., Tyakoe, D., Sepkowitz, K., Tokars, J., Perl, T., Gramatikova, A., Platt, R., Diekema, D. J., Herwaldt, L. A., Climo, M., Wong, E., Noskin, G., Plaskett, T., Solomon, S. & Fraser, V. (2002). Preventing catheter-associated bloodstream infections: A survey of policies for insertion and care of central venous catheters from multiple hospitals.

Pfaller, M. A., Diekema, D. J., Jones, R. N., Messer, S. A. & Hollis, R. J. (2002). Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. Journal of clinical microbiology, 40(3), 852-6. PMID: 11880404.

Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N. & Diekema, D. J. (2002). In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrobial agents and chemotherapy, 46(6), 1723-7. PMID: 12019081.

Richter, S. S., Beekmann, S. E., Croco, J. L., Diekema, D. J., Koontz, F. P., Pfaller, M. A. & Doern, G. V. (2002). Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm. Journal of clinical microbiology, 40(7), 2437-44. PMID: 12089259.

Pfaller, M. A., Diekema, D. J. (2002). Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. Journal of clinical microbiology, 40(10), 3551-7. PMID: 12354845.

Diekema, D. J., BootsMiller, B., Vaughn, T., Ward, M., Ernst, E., Flach, S., Nora, J., Woolson, R., Franciscus, C., Acotsa, E., Pfaller, M. & Doebbeling, B. (2002). Antimicrobial resistance trends and outbreak frequency in United States Hospitals.

Diekema, D. J., Pfaller, M. A. & Jones, R. N. (2002). Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000. International journal of antimicrobial agents, 20(6), 412-8. PMID: 12458134.

Diekema, D. J. (2002). Alcohol-based hand gels and hand hygiene in hospitals. (Vols. 360). (9344), pp. 1510; author reply 1511. Lancet. PMID: 12433544.

Pfaller, M. A., Messer, S. A., Boyken, L., Huynh, H., Hollis, R. J. & Diekema, D. J. (2002). In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrobial agents and chemotherapy, 46(11), 3518-21. PMID: 12384359.

Diekema, D. J., Lee, K., Raney, P., Herwaldt, L. A., Doern, G. V. & Tenover, F. C. (2002). Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures.

Diekema, D. J., Messer, S. A., Hollis, R. J., Jones, R. N. & Pfaller, M. A. (2002). Antifungal activity of caspofungin and the new triazoles compared with itraconazole and amphotericin B against 462 recent clinical isolates of Aspergillus and other filamentous fungi.

Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Huynh, H. & Hollis, R. J. (2002). Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole. Journal of clinical microbiology, 40(5), 1694-7. PMID: 11980944.

Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L. & Hollis, R. J. (2002). Activity of fluconazole and voriconazole determined by broth microdilution, disk diffusion and Etest methods against 1897 recent clinical isolates of Candida species: Report from the ARTEMIS Global Anfungal Susceptibility Program, 2001.

Lewis, R. E., Diekema, D. J., Messer, S. A., Pfaller, M. A. & Klepser, M. E. (2002). Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. The Journal of antimicrobial chemotherapy, 49(2), 345-51. PMID: 11815578.

Diekema, D. J., Messer, S. A., Brueggemann, A. B., Coffman, S. L., Doern, G. V., Herwaldt, L. A. & Pfaller, M. A. (2002). Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. Journal of clinical microbiology, 40(4), 1298-302. PMID: 11923348.

Diekema, D. J., Franciscus, C., Vaughn, T., Ward, M., Woolson, R. F., Pfaller, M. A., Bootsmiller, B. & Doebbeling, B. N. (2001). Clinical microbiology laboratory support for infection control and antimicrobial resistance control.

Nora, J. J., Diekema, D. J., Vaughn, T., Ward, M., Franciscus, C., Bootsmiller, B., Woolson, R. & Doebbeling, B. N. (2001). Implementation of guidelines to control antimicrobial resistance in US hospitals.

Beekmann, S. E., Diekema, D. J., Chapin, K. C. & Doern, G. V. (2001). Patient outcomes and other factors related to rapid detection of bacteremia using a continuous monitoring blood culture system.

Richter, S. S., Beekmann, S. E., Croco, J. L., Diekema, D. J., Koontz, F. P., Pfaller, M. A. & Doern, G. V. (2001). Minimizing the workup of blood culture contaminants: Implementation and evaluation of a laboratory based algorithm.

Nora, J. J., Diekema, D. J., Vaughn, T., Ward, M., Franciscus, C., Bootsmiller, B., Woolson, R. & Doebbeling, B. N. (2001). Antimicrobial resistance in epidemiologically important organisms in US hospitals.

Pfaller, M. A., Jones, R. N., Diekema, D. J. & Beach, M. (2001). Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in North America: SENTRY Program, 1997-2000.

Diekema, D. J., Beach, M. L., Pfaller, M. A. & Jones, R. N. (2001). Nosocomial Staphylococcus aureus bacteremia: A four year update from the SENTRY Antimicrobial Surveillance Program (US and Canada).

Diekema, D. J., Beekmann, S. E., Chapin, K. C. & Doern, G. V. (2001). Epidemiology and outcome of bloodstream infection in the new millennium.

Pfaller, M. A., Diekema, D. J., Jones, R. N., Sader, H. S., Fluit, A. C., Hollis, R. J. & Messer, S. A. (2001). International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. Journal of clinical microbiology, 39(9), 3254-9. PMID: 11526159.

Xiang, J., Wunschmann, S., Diekema, D. J., Klinzman, D., Patrick, K. D., George, S. L. & Stapleton, J. T. (2001). Effect of coinfection with GB virus C on survival among patients with HIV infection. The New England journal of medicine, 345(10), 707-14. PMID: 11547739.

Yamazumi, T., Furuta, I., Diekema, D. J., Pfaller, M. A. & Jones, R. N. (2001). Comparison of the Vitek gram-positive susceptibility 106 card, the MRSA-Screen latex agglutination test, and mecA analysis for detecting oxacillin resistance in a geographically diverse collection of clinical isolates of coagulase-negative staphylococci. Journal of clinical microbiology, 39(10), 3633-6. PMID: 11574584.

Diekema, D. J., Jones, R. N. (2001). Oxazolidinone antibiotics. Lancet, 358(9297), 1975-82. PMID: 11747939.

David, S., Vandeberg, J., Knapp, C., Kuhns, K., Boyken, L., Erenberger, C., Wiblin, R. T., Diekema, D. J. & Herwaldt, L. A. (2001). A cluster of complicated groin wound infections after femoral artery catheterization.

Diekema, D. J., Beach, M. L., Pfaller, M. A. & Jones, R. N. (2001). Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 7(3), 152-7. PMID: 11318814.

Walsh, T. R., Bolmstrom, A., Qwarnstrom, A., Ho, P., Wootton, M., Howe, R. A., MacGowan, A. P. & Diekema, D. (2001). Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. Journal of clinical microbiology, 39(7), 2439-44. PMID: 11427551.

Yamazumi, T., Marshall, S. A., Wilke, W. W., Diekema, D. J., Pfaller, M. A. & Jones, R. N. (2001). Comparison of the Vitek Gram-Positive Susceptibility 106 card and the MRSA-screen latex agglutination test for determining oxacillin resistance in clinical bloodstream isolates of Staphylococcus aureus. Journal of clinical microbiology, 39(1), 53-6. PMID: 11136748.

Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N. & Beach, M. (2001). Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 32 Suppl 2, S114-32. PMID: 11320452.

Hanberger, H., Diekema, D., Fluit, A., Jones, R., Struelens, M., Spencer, R. & Wolff, M. (2001). Surveillance of antibiotic resistance in European ICUs. The Journal of hospital infection, 48(3), 161-76. PMID: 11439002.

Andrews, J. I., Diekema, D. J., Coffman, S., Pfaller, M. A., Jones, R. N. & Doern, G. V. (2000). Group B Streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

Diekema, D. J., Jones, R. N. (2000). Microbiology of infections in the coronary care unit. Antibiotics for Clinicians, 4, 5-10.

Diekema, D. J., Pfaller, M. A., Turnidge, J., Verhoef, J., Bell, J., Fluit, A. C., Doern, G. V. & Jones, R. N. (2000). Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998. Microbial drug resistance (Larchmont, N.Y.), 6(3), 213-21. PMID: 11144421.

Diekema, D. J., Beekmann, S. E., Brueggemann, A. B., Herwaldt, L. A., Pfaller, M. A., Jones, R. N. & Doern, G. V. (2000). Molecular epidemiology of community-acquired oxacillin-resistant Staphylococcus aureus from the Emerging Infections and the Epidemiology of Iowa Organisms (EIEIO) Study.

Diekema, D. J., Jones, R. N. (2000). Microbiology of infections in the coronary care unit. Antibiotics for Clinicians, 23, 5-10.

Klepser, M., Klepser, D., Brooks, J., Ernst, E., Diekema, D. J., Hoffman, H., Mozaffari, E., Hkendrickson, J. & Doern, G. (2000). Examination of healthcare resource utilization associated with the treatment of infections caused by susceptible and non-susceptible isolates of Streptococcus pneumoniae.

Diekema, D. J., Pfaller, M. A., Turnidge, J., Bell, J., Verhoef, J., Fluit, A. C., Beach, M., Stillwell, M. & Jones, R. N. (2000). Oxacillin- and multiple-drug resistance among Staphylococcus aureus: Results of the SENTRY Antimicrobial Resistance Surveillance Program, 1997-1999.

Franciscus, C. J., Vaughn, T. E., Ward, M. M., Diekema, D. J. & Woolson, R. F. (2000). Epidemiology and control of antimicrobial resistance in VA and non-VA hospitals.

Richter, S. S., Diekema, D. J., Beach, M. L., Doern, G. V., Jones, R. N. & Pfaller, M. A. (2000). Agreement between referring laboratory antimicrobial susceptibility test results with the central monitor laboratory when testing bloodstream isolates: SENRY Antimicrobial Resistance Surveillance Program.

Diekema, D. I., Jones, R. N. (2000). Oxazolidinones: a review. Drugs, 59(1), 7-16. PMID: 10718097.

Beekmann, S. E., Diekema, D. J., Brueggemann, A. B., Pfaller, M. A., Jones, R. N., Doern, G. V. & Herwaldt, L. a. (2000). Epidemiology of mecthicillin-resistant Staphylococcus aureus and prevalance of true community-acquired MRSA in an Iowa Statewide Surveillance Network.

Andrews, J. I., Diekema, D. J., Hunter, S. K., Rhomberg, P. R., Pfaller, M. A., Jones, R. N. & Doern, G. V. (2000). Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. American journal of obstetrics and gynecology, 183(4), 859-62. PMID: 11035326.

Diekema, D. J., Pfaller, M. A., Jones, R. N., Doern, G. V., Kugler, K. C., Beach, M. L. & Sader, H. S. (2000). Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. International journal of antimicrobial agents, 13(4), 257-71. PMID: 10755240.

Diekema, D. J., Pfaller, M. A., Beach, M. L., Doern, G. V. & Jones, R. N. (2000). Antimicrobial susceptibility of viridans group streptococci bloodstream isolates from cancer patients at SENTRY centers in the US, Canada, and Latin America.

Beekmann, S. E., Diekema, D. J., Chapin, K. C., Morel, K. A. & Doern, G. V. (2000). Effects of rapid detection of bacteremia using a continuous monitoring blood culture system on measures of patient outcome.

Diekema, D. J. (2000). Drug Resistance.

Diekema, D. J., Brueggemann, A. B. & Doern, G. V. (2000). Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. Emerging infectious diseases, 6(5), 552-6. PMID: 10998390.

Lewis, R. E., Diekema, D. J., Messer, S. A., faller, M. A. & Klepser, M. E. (1999). Comparison of Etest checkerboard dilution, and time-kill testing for the detection of synergy or antagonism among Candida spp.

Diekema, D. J., Marshall, S. A., Deshpande, L. M. & Jones, R. N. (1999). Comparative activity update of clinafloxacin testing against 2,000 contemporary clinical isolates from patients in United States Hospitals.

Diekema, D. J., Pfaller, M. A., Turnidge, J., Verhoef, J., Fluit, A., Doern, G. V. & Jones, R. N. (1999). Genetic relatedness of multidrug-resistant, methicillin-resistant Staphylococcus aureus causing bloodstream infection at SENTRY centers on five continents during 1998.

Pfaller, M. A., Diekema, D. J., Jones, R. N. & Doern, G. V. (1999). Frequency of occurrence and trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the United States, Canada, and Latin America: Report from the SENTRY Antimicrobial Surveillance Program.

Diekema, D. J., Pfaller, M. A., Jones, R. N. & Doern, G. V. (1999). Survey of bloodstream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the SENTRY Antimicrobial Surveillance Program.

Diekema, D. J., Brueggemann, A. B. & Doern, G. V. (1999). Relationship between outpatient antimicrobial usage in metropolitan areas and changes in resistance of Streptococcus pneumoniae at 23 hospitals in the United States.

Diekema, D. J., Coffman, S. L., Marshall, S. A., Beach, M. L., Rolston, K. V. & Jones, R. N. (1999). Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centers. Antimicrobial agents and chemotherapy, 43(4), 940-3. PMID: 10103204.

Diekema, D. J., Marchesseault, A. (1999). Clinical impact of changing to an automated blood-culture system at a small community hospital. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 5(9), 590-593. PMID: 11851718.

Deshpande, L. M., Diekema, D. J. & Jones, R. N. (1999). Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals. Diagnostic microbiology and infectious disease, 35(1), 81-8. PMID: 10529885.

Diekema, D. J., Jones, R. N. (1999). Antimicrobial activity of quinuprstin-dalfopristin against gram-positive bacteria: results from recent studies. Infect Oncol, 3, 6-9.

Diekema, D. J., Pfaller, M. A., Messer, S. A., Houston, A., Hollis, R. J., Doern, G. V. & Jones, R. N. (1999). In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America. Antimicrobial agents and chemotherapy, 43(9), 2236-9. PMID: 10471571.

Diekema, D. J., Pfaller, M. A., Jones, R. N., Doern, G. V., Winokur, P. L., Gales, A. C., Sader, H. S., Kugler, K. & Beach, M. (1999). Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 29(3), 595-607. PMID: 10530454.

Diekema, D. J., Jones, R. N. & Rolston, K. (1999). Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers.

Pfaller, M. A., Diekema, D. J., Messer, S. A., Houston, A., Hollis, R. J., Doern, G. V. & Jones, R. N. (1999). Antifungal activity of BMS-207147, a new triazole antifungal agent, tested against 613 bloodstream isolates of Candida spp. from the SENTRY Antimicrobial Surveillance Program in North America and Latin America.

Diekema, D. J., Jones, R. N. & Rolston, K. V. (1999). Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers. Diagnostic microbiology and infectious disease, 34(1), 37-43. PMID: 10342106.

Diekema, D. J., Doebbeling, B. N. (1998). Employee health and infection control.

Diekema, D. J., Marchesseault, A. (1998). Clinical impact of a continuous-monitoring blood culture system at a small community hospital.

Diekema, D. J., Barr, J., Boyken, L. D., Buschelman, B. J., Jones, R. N., Pfaller, M. A. & Herwaldt, L. A. (1997). A cluster of serious Escherichia coli infections in a neonatal intensive-care unit. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 18(11), 774-6. PMID: 9397375.

Diekema, D. J., Messer, S. A., Hollis, R. J., Wenzel, R. P. & Pfaller, M. A. (1997). An outbreak of Candida parapsilosis prosthetic valve endocarditis. Diagnostic microbiology and infectious disease, 29(3), 147-53. PMID: 9401807.

Diekema, D. J., Albanese, M. A., Schuldt, S. S. & Doebbeling, B. N. (1996). Blood and body fluid exposures during clinical training: relation to knowledge of universal precautions. Journal of general internal medicine, 11(2), 109-11. PMID: 8833019.

Diekema, D. J., Albanese, M. A., Densen, P. & Doebbeling, B. N. (1996). Student health policies of U.S. medical schools. Academic medicine : journal of the Association of American Medical Colleges, 71(10), 1090-2. PMID: 9177643.

Diekema, D. J., Albanese, M. A., Densen, P. & Doebbeling, B. N. (1995). Protecting medical students from infection: A survey of United States medical schools.

Diekema, D. J., Doebbeling, B. N. (1995). Employee health and infection control. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 16(5), 292-301. PMID: 7657978.

Diekema, D. J., Messer, S. A., Hollis, R. J., Pfaller, M. A. & Wenzel, R. P. (1995). An outbreak of Candida parapsilosis prosthetic valve endocarditis.

Diekema, D. J., Schuldt, S. S., Albanese, M. A. & Doebbeling, B. N. (1995). Universal precautions training of preclinical students: impact on knowledge, attitudes, and compliance. Preventive medicine, 24(6), 580-5. PMID: 8610081.

Diekema, D. J., Ferguson, K. J. & Doebbeling, B. N. (1995). Motivation for hepatitis B vaccine acceptance among medical and physician assistant students. Journal of general internal medicine, 10(1), 1-6. PMID: 7699480.

Diekema, D. J., Albanese, M. A., Schulte, S. S. & Doebbeling, B. N. (1994). Universal precautions training of preclinical students: relationship of knowledge to exposure rates during clinical training.

Schuldt, S. S., Diekema, D. J., Albanese, M. A. & Doebbeling, B. N. (1994). Universal precautions training of preclinical students: Impact on knowledge, attitudes and behavior.

Diekema, D. J., Ferguson, K. M. & Doebbeling, B. N. (1994). Motivation for compliance with hepatitis B vaccination among medical student.

Diekema, D. J., Albanese, M. A., Schulte, S. S. & Doebbeling, B. N. (1994). Long term impact of universal precautions training on knowledge, compliance, attitudes and exposures.

Diekema, D. J., Garvin, M. L., Weismann, D. N., Rasley, D. A., Streed, S. & Doebbling, B. N. (1994). The impact of interventions to reduce sharps injuries: a decade of experience.

Doebbeling, B. N., Garvin, M. L., Diekema, D. J. & Weismann, D. N. (1994). Evaluation of interventions to reduce percutaneous injuries in healthcare workers.

Philbrick, J. T., Becker, D. M., Ballew, K. A., Buckley, R. S., Diekema, D. J. & Koberna, P. A. (1992). Risk factors for stroke in nonrheumatic atrial fibrillation. (Vols. 92). (6), pp. 709-10. The American journal of medicine. PMID: 1605159.